Simultaneously combining agents that can accelerate severe ERS to induce cell death along with specific inhibitors of growth factor receptors could serve as another effective strategy exploiting GPCR-ERS crosstalk to prevent tumor progression. The gene discussed is GPBAR1; the disease is neoplasm.